Alpha Tau Medical’s proprietary Alpha DaRT device safely delivers alpha radiation with localized precision to treat cancers. Alpha Tau is waiting for FDA feedback to initiate a US pivotal trial in ...
Bassett Healthcare in Cooperstown is home to a national clinical trial that uses a new radiation therapy for inoperable pancreatic cancer. Dr. Timothy Korytko, the chief of radiation oncology at the ...
JERUSALEM, Nov. 20, 2023 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau") (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT™, and HekaBio K.K.
- Receipt of critical license marks significant milestone for first commercial-scale manufacturing facility for Alpha DaRT ®, the innovative alpha-radiation cancer therapy designed for potent and ...
Armed with a recent breakthrough designation from the FDA for its tumor-destroying radiation technology, Alpha Tau Medical is plowing ahead with plans to go public before the end of the year. To do so ...
Tel Aviv-based Alpha Tau Medical Ltd. raised $26 million in a series B financing. The round was led by previous investors, Savit Capital, Medison Ventures, and Ourcrowd, as well as new private and ...
In the middle of the 20th century, the atom was all the rage. Radiation was the shiny new solution to everything while being similarly poorly understood by the general public and a great deal of those ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback